Cefepime/Zidebactam:
Class: DBO Inhibitor + 4th-Gen Cephalosporin
Potent PBP2 “Enhancer Effect".
Broad serine beta-lactamases and complementary PBP binding against MBLs
Demonstrated success in compassionate-use salvage therapy for extensively drug-resistant, NDM-producing P. aeruginosa #idsky
Antibiotic Steward 🅱️C🆔🅿️🌟
🔥FDA has approved Zaynich (cefepime and zidebactam) for adults with complicated urinary tract infections (cUTIs) caused by designated susceptible microorganisms.🔥 www.accessdata.fda.gov/drugsatfda_d...
